Originalkatalog | Verfügbarkeit prüfen

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon...

Bielen, Rob, Moreno, C., Van Vlierberghe, H., Bourgeois, S., Mulkay, J. -P., Vanwolleghem, T., Verlinden, W., Brixco, C., Decaestecker, J., de Galocsy, C., Janssens, F., Van Overbeke, L., Van Steenkiste, C., D'Heygere, F., Cool, M., Wuyckens, K., Nevens, F., Robaeys, Geert
2017

Originalkatalog | Verfügbarkeit prüfen

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study

Michielsen, P, Bottieau, E, Van Vlierberghe, Hans, Van Marck, E, Vandemaele, E, Denys, M, Brasseur, JP, Popan, M, Assoc Study Liver, Belgian
2009

Originalkatalog | Verfügbarkeit prüfen

Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust Study

Van Vlierberghe, Hans, Adler, M, Bastens, B, Colle, Isabelle, Delwaide, J, Henrion, J, Horsmans, Y, Michielsen, P, Golstein, P, Mulkays, JP, Van Steenbergen, W, Yap, P, Nevens, F, Denys, AM, Brasseur, JP
2010